---
title: "Allosteric Bioscience targets aging with advanced tech. Focus on Lamin A, Tryptophan Metabolism for longevity optimization."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277862977.md"
description: "Allosteric Bioscience, Inc. is utilizing advanced technologies, including Genetics, Genomics, and AI, to explore the Molecular Mechanism of Aging and Longevity. The company focuses on key factors like Lamin A and Tryptophan Metabolism to enhance cellular function and address aging-related diseases. Their research aims to improve understanding of aging mechanisms and potentially extend lifespan."
datetime: "2026-03-05T01:44:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277862977.md)
  - [en](https://longbridge.com/en/news/277862977.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277862977.md)
---

# Allosteric Bioscience targets aging with advanced tech. Focus on Lamin A, Tryptophan Metabolism for longevity optimization.

Allosteric Bioscience, Inc., based in New York, is employing an innovative approach using Genetics, Genomics, Systems Biology, Quantum Computing, Advanced Proprietary AI, and Proprietary Molecular Technologies to delve into and regulate the Molecular Mechanism of Aging and Longevity. Their primary objective is to enhance the aging process and prolong longevity. The focus is on crucial aging factors such as Lamin A, vital for maintaining optimal cellular function, and Tryptophan Metabolism, a key player in numerous aging-related illnesses. This cutting-edge research aims to enhance our understanding of aging mechanisms and potentially boost lifespan.

### Related Stocks

- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ALLO.US](https://longbridge.com/en/quote/ALLO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Tempus AI Expands Collaboration With Gilead Sciences To Maximize Insights In Oncology Pipeline](https://longbridge.com/en/news/282204495.md)
- [Allogene's blood cancer therapy delays cancer relapse in mid-stage study](https://longbridge.com/en/news/282537381.md)
- [BUZZ-Allogene tumbles on $175 mln stock offering after cancer therapy data](https://longbridge.com/en/news/282722450.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment]]>](https://longbridge.com/en/news/282578794.md)
- [FDA issues complete response letter to Replimune’s RP1 for melanoma](https://longbridge.com/en/news/282511585.md)